Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,044 | 831 | 96.2% |
| Education | $556.48 | 10 | 3.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,531 | 190 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,574 | 87 | $0 (2024) |
| Astellas Pharma US Inc | $1,435 | 51 | $0 (2024) |
| Lilly USA, LLC | $1,256 | 99 | $0 (2024) |
| GlaxoSmithKline, LLC. | $860.11 | 71 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $774.82 | 30 | $0 (2024) |
| PFIZER INC. | $675.64 | 36 | $0 (2024) |
| ABBVIE INC. | $639.93 | 30 | $0 (2024) |
| Allergan, Inc. | $561.32 | 11 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $338.03 | 23 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,694 | 83 | Astellas Pharma US Inc ($254.75) |
| 2023 | $2,003 | 112 | Novo Nordisk Inc ($267.87) |
| 2022 | $2,174 | 110 | Novo Nordisk Inc ($412.28) |
| 2021 | $2,271 | 128 | Novo Nordisk Inc ($419.44) |
| 2020 | $1,421 | 83 | Novo Nordisk Inc ($269.06) |
| 2019 | $1,891 | 104 | Novo Nordisk Inc ($440.39) |
| 2018 | $1,484 | 106 | Lilly USA, LLC ($263.41) |
| 2017 | $1,662 | 115 | PFIZER INC. ($235.47) |
All Payment Transactions
841 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $1.91 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Endocrinology | ||||||
| 12/04/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $46.19 | General |
| Category: Endocrinology | ||||||
| 12/02/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.64 | General |
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Gastroenterology | ||||||
| 11/20/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: VACCINES | ||||||
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: DIABETES | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Endocrinology | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Obesity | ||||||
| 11/01/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $23.26 | General |
| Category: Insulin Pump | ||||||
| 10/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: Gastroenterology | ||||||
| 09/30/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: PSYCHIATRY | ||||||
| 09/30/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: PSYCHIATRY | ||||||
| 09/25/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: VACCINE | ||||||
| 09/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Obesity | ||||||
| 09/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: DIABETES | ||||||
| 09/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/10/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 488 | 594 | $111,354 | $53,926 |
| 2022 | 7 | 367 | 414 | $77,771 | $33,021 |
| 2021 | 15 | 771 | 1,186 | $192,033 | $89,857 |
| 2020 | 15 | 1,145 | 2,430 | $374,178 | $185,926 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 111 | 135 | $34,245 | $18,919 | 55.2% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 71 | 139 | $19,043 | $10,783 | 56.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 71 | 71 | $28,400 | $8,871 | 31.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 82 | 94 | $15,980 | $7,614 | 47.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 29 | 29 | $2,465 | $2,086 | 84.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 11 | 11 | $4,400 | $1,758 | 39.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 22 | $2,640 | $1,220 | 46.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 34 | 35 | $1,415 | $1,003 | 70.9% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 13 | 13 | $1,781 | $987.72 | 55.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 31 | 31 | $775.00 | $551.49 | 71.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 13 | 14 | $210.00 | $133.28 | 63.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 81 | 81 | $32,400 | $10,403 | 32.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 97 | 109 | $18,038 | $8,493 | 47.1% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 54 | 75 | $10,275 | $4,919 | 47.9% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Office | 2022 | 29 | 29 | $7,366 | $3,718 | 50.5% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 40 | 51 | $6,987 | $3,039 | 43.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 23 | 23 | $1,725 | $1,576 | 91.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 29 | 29 | $725.00 | $710.75 | 98.0% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 14 | 17 | $255.00 | $162.77 | 63.8% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 99 | 293 | $40,141 | $20,536 | 51.2% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2021 | 65 | 194 | $26,578 | $12,108 | 45.6% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2021 | 72 | 91 | $23,114 | $11,699 | 50.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 79 | 79 | $31,600 | $10,385 | 32.9% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Office | 2021 | 54 | 58 | $14,732 | $7,323 | 49.7% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Facility | 2021 | 44 | 58 | $10,150 | $5,974 | 58.9% |
About Dr. David Pawlowski, MD
Dr. David Pawlowski, MD is a Family Medicine healthcare provider based in Williamsville, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033174958.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Pawlowski, MD has received a total of $14,600 in payments from pharmaceutical and medical device companies, with $1,694 received in 2024. These payments were reported across 841 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($14,044).
As a Medicare-enrolled provider, Pawlowski has provided services to 2,771 Medicare beneficiaries, totaling 4,624 services with total Medicare billing of $362,731. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Williamsville, NY
- Active Since 04/20/2006
- Last Updated 07/13/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1033174958
Products in Payments
- JARDIANCE (Drug) $1,451
- Ozempic (Drug) $918.43
- Saxenda (Drug) $602.74
- FARXIGA (Drug) $467.60
- TRULICITY (Drug) $411.27
- Wegovy (Drug) $378.70
- QULIPTA (Drug) $349.86
- ELIQUIS (Drug) $299.13
- VRAYLAR (Drug) $290.68
- Victoza (Drug) $288.98
- TRELEGY ELLIPTA (Drug) $288.85
- MYRBETRIQ (Drug) $276.52
- Myrbetriq (Drug) $260.55
- TRADJENTA (Drug) $259.57
- ZENPEP (Drug) $258.96
- NURTEC ODT (Drug) $256.28
- Veozah (Drug) $254.75
- MOUNJARO (Drug) $218.26
- Vascepa (Drug) $215.72
- DALVANCE (Drug) $210.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Williamsville
Jean Cange, M.d, M.D
Family Medicine — Payments: $28,012
Dr. Daniel Trock, M.d, M.D
Family Medicine — Payments: $22,227
Suchitra Koneru, M.d, M.D
Family Medicine — Payments: $15,123
Dr. Stacey Gugino, Md, MD
Family Medicine — Payments: $13,585
Dr. Karol Pohlman Rejman, Phd, Fnp, PHD, FNP
Family Medicine — Payments: $12,074
Dr. Michael Dlugosz, M.d, M.D
Family Medicine — Payments: $11,462